This is the limited version of the Plexxikon Inc. company profile: Join LinkedIn or Sign In to see more information.
Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human diseases. It develops a portfolio of clinical and preclinical stage programs in various therapeutic areas, including drug targets for the treatment of metabolic diseases, such as diabetes and obesity indications; melanoma and colorectal cancer, and osteolytic metastatic disease; rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, and osteoporosis; debilitating diseases, including pain and multiple sclerosis; and cardiovascular diseases, which include hypertension and atherosclerosis. The company was founded in 2000 and is headquartered in Berkeley, California.
Your Connections to Plexxikon Inc.
Popular Profiles at Plexxikon Inc.
91 Bolivar Drive
Berkeley, CA
94710
United States
Phone: 510-647-4000
Fax: 510-548-8014
| Top Schools |
| Univ. of California, Berkeley | 12% |
|
Estimated based on LinkedIn Data
Career path for Plexxikon Inc. employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Plexxikon Inc.. This page is not endorsed by or affiliated with Plexxikon Inc.. For questions regarding LinkedIn Company Profiles, contact us.
| 